Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4278-4288

  Ji, Jiaxiang ^a   Sun, Jiaren ^a   Soong, Lynn ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CC CHEMOKINE LIGAND 3; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; RANTES; UNCLASSIFIED DRUG;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; FEMALE; FOOT; GENE EXPRESSION; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; KNOCKOUT MOUSE; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SKIN LEISHMANIASIS; T LYMPHOCYTE; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, PROTOZOAN; CHEMOKINES, CC; CYTOKINES; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA MEXICANA; LEISHMANIASIS, DIFFUSE CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TH1 CELLS;

EID: 0043267774     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4278-4288.2003     Document Type: Article

References (55)

1. Afonso, L. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61:2952-2959.
2. Almeida, R. P., M. Barral-Netto, A. M. De Jesus, L. A. De Freitas, E. M. Carvalho, and A. Barral. 1996. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am. J. Trop. Med. Hyg. 54:178-184.
3. Arend, W. P. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13:323-340.
4. Arend, W. P., H. G. Welgus, R. C. Thompson, and S. P. Eisenberg. 1990. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J. Clin. Investig. 85:1694-1697.
5. Arnoldi, J., and H. Moll. 1998. Langerhans cell migration in murine cutaneous leishmaniasis: regulation by tumor necrosis factor α, interleukin-1β, and macrophage inflammatory protein-1α. Dev. Immunol. 6:3-11.
6. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257:545-548.
7. Barral-Netto, M., R. L. Von Sohsten, M. Teixeira, W. L. dos Santos, M. L. Pompeu, R. A. Moreira, J. T. Oliveira, B. S. Cavada, E. Falcoff, and A. Barral. 1996. In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensis. Acta Trop. 60:237-250.
8. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194:1497-1506.
9. Bhattacharyya, S., S. Ghosh, B. Dasgupta, D. Mazumder, S. Roy, and S. Majumdar. 2002. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J. Infect. Dis. 185:1704-1708.
10. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-134.
11. Bourreau, E., G. Prevot, J. Gardon, R. Pradinaud, and P. Launois. 2001. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J. Infect. Dis. 184:1628-1630.
12. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542.
13. Buates, S., and G. Matlashewski. 2001. General suppression of macrophage gene expression during Leishmania donovani infection. J. Immunol. 166:3416-3422.
14. Caceres-Dittmar, G., F. J. Tapia, M. A. Sanchez, M. Yamamura, K. Uyemura, R. L. Modlin, B. R. Bloom, and J. Convit. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. Immunol. 91:500-505.
15. Charlab, R., C. Blaineau, D. Schechtman, and M. A. Barcinski. 1990. Granulocyte-macrophage colony-stimulating factor is a growth-factor for promastigotes of Leishmania mexicana amazonensis. J. Protozool. 37:352
16. Cillari, E., M. Dieli, E. Maltese, S. Milano, A. Salerno, and F. Y. Liew. 1989. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-α. J. Immunol. 143:2001-2005.
17. Colmenares, M., S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt. 2002. Mechanisms of pathogenesis: differences amongst Leishmania species. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1):S3-S7.
18. Convit, J., M. Ulrich, C. T. Fernandez, F. J. Tapia, G. Caceres-Dittmar, M. Castes, and A. J. Rondon. 1993. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 87:444-448.
19. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53.
20. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397-440.
21. Ferretti, M. 1994. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J. Clin. Investig. 94:449-453.
22. Gerard, N. P., and C. Gerard. 2001. Chemokines and disease. Nat. Cell Biol. 3:E53-E54.
23. Grimaldi, G., Jr., and R. B. Tesh. 1993. Leishmaniases of the New World: current concepts and implications for future research. Clin. Microbiol. Rev. 6:230-250.
24. Gu, L., S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-411.
25. Hedrick, J. A., A. Helms, A. Vicari, and A. Zlotnik. 1998. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood 91:4242-4247.
26. Himmelrich, H., P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Rocken, and J. A. Louis. 2000. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164:4819-4825.
27. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156-6163.
28. Holaday, B. J., M. D. Sadick, Z. E. Wang, S. L. Reiner, F. P. Heinzel, T. G. Parslow, and R. M. Locksley. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147:1653-1658.
29. Ji, J., J. Sun, Q. Hai, and L. Soong. 2002. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66:338-345.
30. Jones, D. E., M. R. Ackermann, U. Wille, C. A. Hunter, and P. Scott. 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect. Immun. 70:2151-2158.
31. Jones, D. E., L. U. Buxbaum, and P. Scott. 2000. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165:364-372.
32. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
33. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:1063-1068.
34. Kovalovsky, D., D. Refojo, F. Holsboer, and E. Arzt. 2000. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J. Neuroimmunol. 109:23-29.
35. Launois, P., K. G. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317-3324.
36. Lonardoni, M. V., M. Russo, and S. Jancar. 2000. Essential role of platelet-activating factor in control of Leishmania amazonensis infection. Infect. Immun. 68:6355-6361.
37. Luster, A. D. 2002. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14:129-135.
38. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2:102-107.
39. Matte, C., and M. Olivier. 2002. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J. Infect. Dis. 185:673-681.
40. Ohmori, Y., L. Wyner, S. Narumi, D. Armstrong, M. Stoler, and T. A. Hamilton. 1993. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 142:861-870.
41. Petersen, E. A., F. A. Neva, A. Barral, R. Correa-Coronas, H. Bogaert-Diaz, D. Martinez, and F. E. Ward. 1984. Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J. Immunol. 132:2603-2606.
42. + T cells in vivo. J. Immunol. 167:4534-4542.
43. Racoosin, E. L., and S. M. Beverley. 1997. Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp. Parasitol. 85:283-295.
44. Ritter, U., and H. Korner. 2002. Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol. 24:295-301.
45. Ritter, U., and H. Moll. 2000. Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-γ and is antagonized by IL-4. Eur. J. Immunol. 30:3111-3120.
46. Ritter, U., H. Moll, T. Laskay, E. Brocker, O. Velazco, I. Becker, and R. Gillitzer. 1996. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 173:699-709.
47. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
48. Soares, L. R., and M. A. Barcinski. 1992. Differential production of granulocyte-macrophage colony-stimulating factor by macrophages from mice susceptible and resistant to Leishmania mexicana amazonensis. J. Leukoc. Biol. 51:220-224.
49. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374-5383.
50. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273.
51. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-824.
52. Tapia, F. J., G. Gaceres-Dittmar, and M. A. Sanchez. 1994. Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunol. Today 15:160-165.
53. Turco, S. J., G. F. Spath, and S. M. Beverley. 2001. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17:223-226.
54. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9:1-11.
55. Zlotnik, A., and K. W. Moore. 1991. Interleukin 10. Cytokine 3:366-371.